Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8656 to 8670 of 8907 results

  1. New option for adult leukaemia patients as we recommend treatment

    Today we've recommended an immunotherapy treatment that could prevent blood cancer from returning in adults who've responded well to initial therapy.

  2. Green light for groundbreaking personalised cancer therapy that reprogrammes immune system

    We've recommended an innovative one-off cell therapy that could give hundreds of lymphoma patients precious extra time with loved ones.

  3. New life-changing treatment option recommended for type of rare epilepsy

    This marks a significant step forward for around 1,400 people living with this rare and severe form of epilepsy, which typically begins in early childhood.

  4. Planning for the International Recognition Procedure

    5 ways NICE Advice can help you navigate this new opportunity alongside health technology assessment.

  5. NICE announces proposals to transform its HealthTech programme to drive more technology into the NHS

    Consultation launches on the biggest shake-up of NICE's HealthTech programme to date.

  6. NICE describes how weight loss drug tirzepatide will be rolled out

    The medication will initially be offered only to those people with the highest clinical needs.

  7. NICE and NIHR: an enduring partnership

    An insight into one of NICE’s most long-standing collaborative relationships.

  8. NICE recommends 2 new breast cancer drugs

    NICE recommends Piqray and Trodelvy, maintaining 100% approvals of breast cancer drugs since 2018.

  9. Tributes paid following the death of founding NICE chairman Professor Sir Mike Rawlins

    Founding chairman led NICE from 1999 to 2013, through its early years to its current position as a world leader in health and social care guidance and medicine evaluation.

  10. NICE recommends Enhertu for more people with advanced breast cancer

    Hundreds more people eligible for breast cancer drug Enhertu as NICE recommends it for earlier stage disease, in final draft guidance.

  11. NICE chronic lung disease treatment decision could benefit 5,200 people

    NICE broadens nintedanib recommendation on chronic lung disease treatment.

  12. Improvements for people with acute kidney injury in updated quality standard

    An updated quality standard published today (23 March 2023) by NICE outlines improvements in care for people who have or are at risk of acute kidney injury.

  13. NICE recommends life-changing gene therapy for children with ultra-rare genetic disorder

    The first and currently only gene therapy for children with an ultra-rare genetic disorder has been recommended by NICE.

  14. Four innovative tests for diagnosing UTIs could help in the fight against antimicrobial resistance

    NHS may use innovative tests which may help people with a urinary tract infection (UTI) receive the correct course of antibiotics more quickly.

  15. NICE recommended weight-loss drug to be made available in specialist NHS services

    Thousands of people will soon be able to be prescribed a drug to help them lose weight as part of their treatment in an NHS specialist weight management service.